arrow
H

Hemant S. Murthy

Mayo Clinic
H指数:30
被引数:3,120

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

一种用于成人同种异基因造血细胞移植受者的活生物疗法产品:一项部分随机、安慰剂对照的1b期临床试验

2026-11-030
OAAI
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

移植物抗宿主病预防措施塑造造血细胞移植后的T细胞生物学和免疫重建

2026-10-210
PRE
Coronary Artery Calcification as a Predictor of Survival in Patients Receiving Post-transplant Cyclophosphamide for GVHD Prophylaxis

冠状动脉钙化作为接受移植后环磷酰胺预防GVHD患者的生存预测因子

2026-09-012
OAAI
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study
Leukemia
IF13.4
2026-08-310
PRE
Impact of Conditioning Regimen Intensity and Total Body Irradiation on Outcomes of Allogeneic Hematopoietic Cell Transplantation for Mature T-Cell Lymphomas: A Multicenter Analysis

异基因造血细胞移植中预处理方案强度和全身照射对成熟T细胞淋巴瘤预后的影响:一项多中心分析

2026-08-100
PRE
Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignancies

血液恶性肿瘤异基因造血细胞移植后早期死亡的危险因素

2026-08-070
PRE
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients

慢性髓系单核细胞白血病患者行异基因干细胞移植与未移植者的风险调整生存比较:梅奥诊所775例连续患者的经验

2026-07-280
PRE
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma

CTX110作为异基因CD19靶向CAR-T疗法在复发/难治性B细胞非霍奇金淋巴瘤中的安全性与有效性

2026-05-070
OAAI
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients

CPX-351(脂质体阿糖胞苷和柔红霉素)与维奈克拉联合表观遗传药物疗法在初诊急性髓系白血病中的比较:一项涉及600例梅奥诊所患者的回顾性比较研究

2026-04-060
OAAI
Efficacy of eltrombopag for treatment of thrombocytopenia in the setting of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis

Eltrombopag治疗异基因造血细胞移植背景下血小板减少症的疗效:一项系统评价和Meta分析

2025-12-050
PRE
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

异基因干细胞移植在慢性髓单核细胞白血病中的应用:对138例梅奥诊所患者移植后生存及危险因素的分析

2025-10-060
OA
Clinical outcomes of allogeneic cell transplantation for patients with chronic myeloid leukemia

异基因细胞移植治疗慢性髓性白血病患者的临床结局

2025-10-010
PRE
Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B-cell acute lymphoblastic leukaemia

接受CD19 × CD22双顺反子嵌合抗原受体T细胞治疗的B细胞急性淋巴细胞白血病患者出现四肢轻瘫

2025-08-250
OAAI
Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis

嵌合抗原受体T细胞疗法治疗Richter转化:一项CIBMTR分析

2025-08-050
PRE
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis

tisagenleucel治疗后B-Cell ALL患者感染的实时世界结局:一项CIBMTR分析

2025-08-050
OAAI
Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm

移植后重组人粒细胞集落刺激因子和地西他滨维持治疗在高风险髓系肿瘤患者中的疗效

2025-07-290
OAAI
Assessing Physical Function in Transplantation and CAR-T Recipients: Expert Recommendations from the Survivorship, Aging and Biobehavioral Special Interest Groups of ASTCT

评估移植和CAR-T接受者的躯体功能:ASTCT生存、衰老与生物行为特别兴趣小组的专家建议

2025-06-010
PRE
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

CD19嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后的感染:CIBMTR的真实世界分析

2025-05-300
OAAI
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines

美国老年评估实践:针对接受造血细胞移植或嵌合抗原受体T细胞治疗的老年人——移植与细胞治疗学会老年特别兴趣小组与实践指南委员会医师调查

2025-02-010
PRE
PREDICTIVE PERFORMANCE OF EARLY WARNING SCORING SYSTEMS FOR ICU TRANSFER FOLLOWING CAR-T THERAPY

CAR-T疗法后ICU转诊的早期预警评分系统的预测性能

2025-01-300
PRE